FDA.reportPublic FDA data

lanthanum carbonate 750 MG Oral Powder

RxCUI
1551885
RxNorm name
lanthanum carbonate 750 MG Oral Powder
Display name
lanthanum carbonate 750 MG Oral Powder
Full name
lanthanum carbonate 750 MG Oral Powder
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FosrenolLANTHANUM CARBONATETakeda Pharmaceuticals America, Inc.f10776b2-2c25-4343-aabe-68f302e5cb542024-12-31Warnings, Adverse reactionsExact identifier
rxcui: 1551885

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f10776b2-2c25-4343-aabe-68f302e5cb54lanthanum carbonate 750 MG Oral Powder [PSN] · lanthanum carbonate 750 MG Oral Powder [SCD]258These highlights do not include all the information needed to use FOSRENOL safely and effectively. See full prescribing information for FOSRENOL. FOSRENOL ® (lanthanum carbonate) chewable tablets, for oral use FOSRENOL ® (lanthanum carbonate) oral powder, for oral use Initial U.S. Approval: 200420241231